We are live on ! Find out more
ADILW

Adial Pharmaceuticals Warrant
ADILW

Delisted

ADILW was delisted on the 27th of July, 2023.

Back to rankings

2 hedge funds and large institutions have $1.45K invested in Adial Pharmaceuticals Warrant in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

64% less capital invested

Capital invested by funds: $4K → $1.45K (-$2.55K)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
1
Ameriprise
Minnesota
$1K – – –
WAM
2
Wolverine Asset Management
Illinois
$450 – – –

ADILW Hedge Fund Activity: Q4 2022 in Review

2 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals Warrant (ADILW) for Q4 2022, worth a combined $1.45K — down 64% from $4K a quarter earlier.

Fund positioning in ADILW was balanced in Q4 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Adial Pharmaceuticals Warrant (ADILW) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $1.45K of Adial Pharmaceuticals Warrant stock for Q4 2022, down 64% quarter-over-quarter.
  • 0 funds opened new Adial Pharmaceuticals Warrant positions in Q4 2022 and 0 closed out.

Based on aggregated 13F filings for Q4 2022.